Vetanco International Acknowledgment for Sherry Layton, Vetanco Scientific Director

Sherry Layton, Vetanco Scientific Director, will be awarded in the 12th International Conference on Emerging Infectious Diseases

PDF) Development and evaluation of candidate recombinant Salmonella-vectored Salmonella vaccines

PDF) Development and initial evaluation of a candidate Clostridium perfringens a toxin-based necrotic enteritis vaccine utilizing recombinant Salmonella as a vaccine vector

News - BV Science

PDF) Role of Gut Microbiota in Cardiovascular Disease that Links to Host Genotype and Diet

Vaccines Conference-2022, Global Conference on Vaccines Research and Development